Raghunath, A., Sundarraj, K., Arfuso, F., Sethi, G., Perumal, E., & PHARMACOLOGY. (2021). Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance. MDPI AG.
استشهاد بنمط شيكاغوRaghunath, A., K. Sundarraj, F. Arfuso, G. Sethi, E. Perumal, و PHARMACOLOGY. Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance. MDPI AG, 2021.
MLA استشهادRaghunath, A., et al. Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance. MDPI AG, 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.